Protagonist Therapeutics, Inc. (PTGX)
84.75
-0.48
(-0.56%)
USD |
NASDAQ |
Jan 15, 16:00
84.60
-0.15
(-0.18%)
After-Hours: 20:00
Protagonist Therapeutics SG&A Expense (TTM): 42.37M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 23.38B |
| ADMA Biologics, Inc. | 96.37M |
| Bristol Myers Squibb Co. | 7.222B |
| MannKind Corp. | 195.42M |
| Regeneron Pharmaceuticals, Inc. | 2.717B |